Lung Quality Measures

The Lung Program strives to deliver top-quality care to all patients. As part of this responsibility, we are committed to providing transparency across lung transplant graft and patient survival rates, as well as outcome of care measures for Medicare patients with lung-related conditions.

The information below provides an in-depth look at the data for lung transplants performed by Cedars-Sinai, including graft and patient survival rates in one-month, one-year, and three-year intervals. These measures are compared against national averages, and reported to the United Network for Organ Sharing, a regulatory body for organ transplants.

The 30-day readmission and mortality rate data below, as shared with the Center for Medicare and Medicaid Services, provides insight into how well Cedars-Sinai is performing at preventing complications in Medicare patients who are 65 years or older, resulting from pneumonia and chronic obstructive pulmonary disease (COPD).

All of these reports aim to reduce ambiguity in outcome data, providing patients and their loved ones the information they need to make decisions with utmost confidence regarding their medical care.

Pneumonia & Chronic Obstructive Pulmonary Disease

Venous Thromboembolism

The Joint Commission has established treatment guidelines that, can help patients recover more quickly with fewer complications or lasting effects. Cedars-Sinai's performance for The Joint Commission measures compared to other medical centers and hospitals around the nation are highlighted below.

The following measures are based on evidence that the practices described below lead to better outcomes for patients at risk for a venous thromboembolism.

Have Questions or Need Help?

If you have questions or wish to learn more about quality measures at Cedars-Sinai, please send us a message.